These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36733284)

  • 1. Association between the risk of heart failure hospitalization and end-stage renal disease with digoxin usage in patients with cardiorenal syndrome: A population-based study.
    Chang KT; Kuo HF; Chang YH; Wang YT; Yang LJ; Niu SW; Kuo IC; Chen Y; Wen ZH; Hung CC; Chang JM; Lin HY
    Front Public Health; 2022; 10():1074017. PubMed ID: 36733284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thiazide and thiazide-like diuretics are associated with improved cardiovascular and renal outcomes in patients with chronic kidney disease.
    Lin HY; Chang YH; Wang YT; Liang PI; Hung CC; Chang JM; Dai DF; Lin CS; Chang KT
    Ann Acad Med Singap; 2023 Oct; 52(10):510-521. PubMed ID: 38920202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of digoxin with mortality in patients with advanced chronic kidney disease: A population-based cohort study.
    Yang LJ; Hsu SM; Wu PH; Lin MY; Huang TH; Lin YT; Kuo HT; Chiu YW; Hwang SJ; Tsai JC; Chen HC
    PLoS One; 2021; 16(1):e0245620. PubMed ID: 33449946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incident Atrial Fibrillation and the Risk of Congestive Heart Failure, Myocardial Infarction, End-Stage Kidney Disease, and Mortality Among Patients With a Decreased Estimated GFR.
    Massicotte-Azarniouch D; Kuwornu JP; Carrero JJ; Lam NN; Molnar AO; Zimmerman D; McCallum MK; Garg AX; Sood MM
    Am J Kidney Dis; 2018 Feb; 71(2):191-199. PubMed ID: 29153994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term impact of cardiorenal syndromes on major outcomes based on their chronology: a comprehensive French nationwide cohort study.
    Halimi JM; de Fréminville JB; Gatault P; Bisson A; Gueguen J; Goin N; Sautenet B; Maisons V; Herbert J; Angoulvant D; Fauchier L
    Nephrol Dial Transplant; 2022 Nov; 37(12):2386-2397. PubMed ID: 35438794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The impact of digoxin on the long-term outcomes in patients with coronary artery disease and atrial fibrillation].
    Qiao Y; Wang Y; Jiang CX; Li SN; Sang CH; Tang RB; Long DY; Wu JH; He L; Du X; Dong JZ; Ma CS
    Zhonghua Nei Ke Za Zhi; 2021 Sep; 60(9):797-805. PubMed ID: 34445815
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical outcomes and 30-day readmissions for heart failure with reduced ejection fraction with cardiorenal syndrome: A National Cohort Study.
    Shanah L; Mir T; Uddin MM; Hussain T; Parajuli T; Bhat Z
    Int J Cardiol; 2023 Jan; 370():244-249. PubMed ID: 36328112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of digoxin intoxication caused by clarithromycin-digoxin interactions in heart failure patients: a population-based study.
    Chan AL; Wang MT; Su CY; Tsai FH
    Eur J Clin Pharmacol; 2009 Dec; 65(12):1237-43. PubMed ID: 19655133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Statin Therapy With Major Adverse Cardiovascular and Limb Outcomes in Patients With End-stage Kidney Disease and Peripheral Artery Disease Receiving Maintenance Dialysis.
    Lo HY; Lin YS; Lin DS; Lee JK; Chen WJ
    JAMA Netw Open; 2022 Sep; 5(9):e2229706. PubMed ID: 36048442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Chronic Digoxin Use on Mortality and Heart Failure Hospitalization in Pulmonary Arterial Hypertension.
    Chang KY; Giorgio K; Schmitz K; Walker RF; Prins KW; Pritzker MR; Archer SL; Lutsey PL; Thenappan T
    J Am Heart Assoc; 2023 Mar; 12(6):e027559. PubMed ID: 36892094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type 2 diabetes and cardiorenal syndromes. A nationwide French hospital cohort study.
    Maisons V; Halimi JM; Fauchier G; de Fréminville JB; Goin N; Gueguen J; Gatault P; Sautenet B; Angoulvant D; Herbert J; Bisson A; Ducluzeau PH; Fauchier L
    Diabetes Metab; 2023 May; 49(3):101441. PubMed ID: 36931430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of angiotensin-converting enzyme inhibitors and digoxin on health outcomes of very old patients with heart failure. SAGE Study Group. Systematic Assessment of Geriatric drug use via Epidemiology.
    Gambassi G; Lapane KL; Sgadari A; Carbonin P; Gatsonis C; Lipsitz LA; Mor V; Bernabei R
    Arch Intern Med; 2000 Jan; 160(1):53-60. PubMed ID: 10632305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incident Hospitalization with Major Cardiovascular Diseases and Subsequent Risk of ESKD: Implications for Cardiorenal Syndrome.
    Ishigami J; Cowan LT; Demmer RT; Grams ME; Lutsey PL; Carrero JJ; Coresh J; Matsushita K
    J Am Soc Nephrol; 2020 Feb; 31(2):405-414. PubMed ID: 31919105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential effects of digoxin on long-term renal and clinical outcomes in chronic heart failure.
    Testani JM; Brisco MA; Tang WH; Kimmel SE; Tiku-Owens A; Forfia PR; Coca SG
    J Card Fail; 2013 May; 19(5):295-302. PubMed ID: 23663810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-acteyl-ß-D-glucosaminidase and kidney injury molecule-1: New predictors for long-term progression of chronic kidney disease in patients with heart failure.
    Jungbauer CG; Uecer E; Stadler S; Birner C; Buchner S; Maier LS; Luchner A
    Nephrology (Carlton); 2016 Jun; 21(6):490-8. PubMed ID: 26422793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes prevalence and outcomes in hospitalized cardiorenal-syndrome patients with and without hyponatremia.
    Pliquett RU; Schlump K; Wienke A; Bartling B; Noutsias M; Tamm A; Girndt M
    BMC Nephrol; 2020 Sep; 21(1):393. PubMed ID: 32912147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between Digoxin Use and Adverse Outcomes Among Patients in the Chinese Atrial Fibrillation Registry.
    Gao Y; Chang S; Du X; Dong J; Xu X; Zhou Y; Lip GYH; Ma C
    Am J Cardiovasc Drugs; 2019 Dec; 19(6):579-587. PubMed ID: 31077081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex-based differences in the effect of digoxin for the treatment of heart failure.
    Rathore SS; Wang Y; Krumholz HM
    N Engl J Med; 2002 Oct; 347(18):1403-11. PubMed ID: 12409542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Digoxin is associated with worse outcomes in patients with heart failure with reduced ejection fraction.
    Zhou J; Cao J; Jin X; Zhou J; Chen Z; Xu D; Yang X; Dong W; Li L; Fan Y; Chen L; Zhong Q; Fu M; Hu K; Ge J;
    ESC Heart Fail; 2020 Feb; 7(1):138-146. PubMed ID: 31994361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. End-stage renal disease versus death in a Portuguese cohort of elderly patients: an approach using competing event analysis.
    Santos J; Fonseca I; Malheiro J; Beirao I; Lobato L; Oliveira P; Cabrita A
    J Investig Med; 2017 Oct; 65(7):1041-1048. PubMed ID: 28729248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.